Inhibikase Therapeutics (IKT) Reiterated at Overweight by Cantor Fitzgerald May 19, 2026 07:14AM
Cantor Fitzgerald Starts Inhibikase Therapeutics Inc (IKT) at Overweight Dec 11, 2025 08:04AM
Inhibikase prices $100 million stock offering at $1.45 per share Nov 20, 2025 09:54PM
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants Nov 20, 2025 09:54PM
Inhibikase Therapeutics announces public offering of stock Nov 20, 2025 04:12PM


Nov 20, 2025 04:12PM Inhibikase Therapeutics announces public offering of stock
Nov 20, 2025 04:12PM Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants